Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome.

Elisa UntiSonia MazzucchiRosanna CalabreseGiovanni PalermoEleonora Del PreteUbaldo BonuccelliRoberto Ceravolo

Published in: Brain and behavior (2019)

Our study confirms safety, efficacy, and tolerability of BoTNA in the treatment of dystonia associated with CBS. Local treatment should be considered as a valid alternative to oral treatment modulation mainly in the presence of associated pain.

Keyphrases

chronic pain
randomized controlled trial
early onset
combination therapy
neuropathic pain
spinal cord
case report